AntiCancer Agents in Medicinal Chemistry, 8(3), 313321
Authors' contributions: JS and DF participated in the conception and design of the review, revised the whole manuscript, and read and approved the final manuscript
Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment
Originally developed in Australia in the 1990s, it was designed to harness the fat-burning properties of growth hormone without triggering its broader hormonal effects
Mechanism: Limited laboratory research suggests Epithalon may influence cellular processes involved in skin aging by protecting fibroblasts (collagen-producing cells) from oxidative stress
Contact our Dermatology Clinic to schedule your consultation with our experienced team of dermatologists